CL
MDT icon

Croft-Leominster’s Medtronic MDT Stock Holding History

Croft-Leominster’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$589K Sell
7,294
-30,833
-81% -$2.47M 0.55% 52
2017
Q3 		$2.96M Buy
38,127
+2,394
+7% +$199K 0.7% 55
2017
Q2 		$3.17M Buy
35,733
+67
+0.2% +$5.65K 0.75% 56
2017
Q1 		$2.87M Buy
+35,666
New +$2.79M 0.68% 55
2016
Q4 		– Hold
0
– – – 60

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Croft-Leominster's MDT Position: Q4 2017 in Review

Croft-Leominster reduced its Medtronic (MDT) stake by 81% in Q4 2017, selling an estimated $2.47M and leaving 7,294 shares worth $589K. The position accounts for 0.55% of the portfolio, ranked #52.

Croft-Leominster first reported a position in MDT in Q1 2017 and has held it in 4 quarters since. The position peaked at $3.17M in Q2 2017. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • Croft-Leominster held 7,294 shares of Medtronic worth $589K as of Q4 2017.
  • Croft-Leominster sold 30,833 Medtronic shares in Q4 2017, an estimated $2.47M.
  • Medtronic made up 0.55% of Croft-Leominster's portfolio in Q4 2017, its #52 holding.
  • Croft-Leominster first reported a position in Medtronic in Q1 2017 and has held it in 4 quarters since.
  • Croft-Leominster's Medtronic position peaked at $3.17M in Q2 2017.
  • 1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Croft-Leominster's 13F filing for Q4 2017, filed 6 Mar 2018.